European medicines regulatory authorities
E387633
European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
All labels observed (5)
How this entity was disambiguated
This entity first appeared as the object of triple T3767712 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: European medicines regulatory authorities Context triple: [Certificates of Suitability, recognizedBy, European medicines regulatory authorities]
-
A.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
B.
Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
European Union pharmaceutical legislation
European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: European medicines regulatory authorities Target entity description: European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
-
A.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
B.
Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
European Union pharmaceutical legislation
European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
government agency
ⓘ
medicines regulatory authority ⓘ public health authority ⓘ |
| aimsTo |
ensure efficacy of medicines
ⓘ
ensure quality of medicines ⓘ ensure safety of medicines ⓘ protect public health ⓘ |
| canRevoke | marketing authorisations ⓘ |
| canSuspend | marketing authorisations ⓘ |
| cooperateWith |
European Commission
ⓘ
European Medicines Agency ⓘ World Health Organization ⓘ other national medicines agencies ⓘ |
| follows |
European Union pharmaceutical legislation
ⓘ
ICH E6 Good Clinical Practice ⓘ
surface form:
Good Clinical Practice guidelines
Good Manufacturing Practice guidelines ⓘ Good Pharmacovigilance Practice guidelines ⓘ |
| hasRole |
authorization of medicinal products
ⓘ
benefit–risk assessment of medicines ⓘ enforcement of medicines legislation ⓘ evaluation of medicinal products ⓘ inspection of clinical trials ⓘ inspection of manufacturing sites ⓘ market surveillance of medicines ⓘ pharmacovigilance ⓘ quality control of medicines ⓘ regulation of clinical trials ⓘ |
| issues | safety warnings for medicines ⓘ |
| locatedIn | Europe ⓘ |
| maintains | national pharmacovigilance systems ⓘ |
| monitors | adverse drug reactions ⓘ |
| partOf |
European medicines regulatory authorities
self-linksurface differs
ⓘ
surface form:
European medicines regulatory network
|
| provides |
information on medicines to healthcare professionals
ⓘ
information on medicines to the public ⓘ scientific advice to medicine developers ⓘ |
| regulates |
advanced therapy medicinal products
ⓘ
biological medicinal products ⓘ generic medicines ⓘ human medicinal products ⓘ over-the-counter medicines ⓘ prescription-only medicines ⓘ vaccines ⓘ veterinary medicinal products ⓘ |
| usesProcedure |
centralised marketing authorisation procedure
ⓘ
decentralised marketing authorisation procedure ⓘ mutual recognition procedure ⓘ national marketing authorisation procedure ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: European medicines regulatory authorities Description of subject: European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
Referenced by (8)
Full triples — surface form annotated when it differs from this entity's canonical label.